The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
A global biotechnology company is laying off 150 people as it ceases manufacturing operations at a Cambridge facility. The layoffs at GlaxoSmithKline, or GSK, will go into effect between Oct. 4 and ...
Veterans of the biotech business sometimes talk about surviving various “winters” for their industry — periods when funding drops and companies cut jobs or shut down entirely. They’re living through a ...
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results